Chloroquine for COVID-19 Infection
Drug Saf
.
2020 May;43(5):393-394.
doi: 10.1007/s40264-020-00933-4.
Author
Nicholas Moore
1
Affiliation
1
Bordeaux PharmacoEpi, INSERM CIC1401, Bordeaux, France. nicholas.moore@u-bordeaux.fr.
PMID:
32266694
PMCID:
PMC7138193
DOI:
10.1007/s40264-020-00933-4
No abstract available
Publication types
Editorial
MeSH terms
Betacoronavirus / drug effects*
COVID-19
COVID-19 Drug Treatment
Chloroquine / therapeutic use*
Coronavirus Infections / drug therapy*
Humans
Pandemics
Pneumonia, Viral / drug therapy*
SARS-CoV-2
Substances
Chloroquine